THC-O, short for THC-O-acetate, is a synthetic cannabinoid made by chemically modifying THC with an acetate group. It does not occur naturally in the cannabis or hemp plant. Often marketed as two to three times stronger than regular THC, it gained popularity in the early 2020s as a legal gray-area product before the DEA classified it as a Schedule I controlled substance.
How THC-O Differs From Regular THC
THC-O starts with a familiar molecule. Its base structure is the same Delta-9 THC (or Delta-8 THC) found in cannabis, but with one key modification: an acetate group is chemically bonded to the molecule. That acetate group changes how the compound behaves in your body. Rather than activating cannabinoid receptors on its own right away, THC-O likely functions as a prodrug. Your body has to strip away the acetate group first, converting it back into active THC before you feel anything.
This prodrug mechanism is why THC-O’s effects can take longer to kick in, especially in edible form, and why the experience can feel more intense. The acetate group may also increase the compound’s ability to cross into fatty tissues and the brain, which some researchers believe accounts for the reported boost in potency. One animal study found THC-O-acetate has roughly twice the potency of standard THC, and online sources commonly cite a range of two to three times stronger, though human clinical data is extremely limited.
How THC-O Is Made
THC-O cannot be extracted from any cannabis plant. It has to be synthesized in a lab. The process typically starts with hemp-derived CBD, which is first converted into Delta-8 THC through an acid-catalyzed reaction. That Delta-8 THC is then treated with acetic anhydride, a highly flammable and corrosive chemical, to attach the acetate group.
This is not a process anyone should attempt outside a professional chemistry lab. Acetic anhydride is dangerous to handle, and the reaction requires precise temperature control and proper ventilation. The lack of manufacturing standards in the unregulated cannabinoid market has raised concerns about residual chemicals, heavy metals, and inconsistent potency in finished products.
What THC-O Actually Feels Like
One of the most common marketing claims about THC-O is that it produces psychedelic or spiritual effects. The first study to actually test this claim found that’s largely not true. Researchers used a validated questionnaire designed to measure psychedelic experiences and found that participants scored well below the threshold for a “complete mystical experience” on every dimension measured. When asked directly, 79% of users said THC-O was “not at all” or only “a little” psychedelic.
What users did report was a low to moderate level of cognitive distortion: altered sense of time, difficulty concentrating, and short-term memory issues. Few reported visuals or hallucinations. In other words, THC-O feels like a stronger version of regular THC for most people, not a fundamentally different experience. The higher potency can make overconsumption easier, especially for people used to standard cannabis products.
When vaped or smoked, effects typically begin within 1 to 10 minutes, similar to other inhaled cannabinoids. Edible forms take considerably longer because the compound must pass through the digestive system before the body can strip the acetate group and release active THC. This delayed onset increases the risk of taking too much before feeling the first dose.
Serious Safety Concerns With Vaping
The most alarming safety issue with THC-O involves what happens when you heat it. Because THC-O contains an acetate group, it shares a chemical trait with vitamin E acetate, the additive linked to the 2019 EVALI outbreak that caused 2,807 hospitalizations and 68 deaths in the United States.
When acetate compounds are heated in a vaping device, they can break down and release ketene, a highly poisonous gas that damages lung tissue. Research has confirmed that ketene forms when cannabinoid acetates are vaped, with production increasing at higher temperatures and with repeated puffs. Ketene was detectable from cannabinoid acetates at temperatures as low as 278°C (about 532°F) on a dabbing platform, and the presence of oxygen significantly increased ketene generation. Standard vaping devices routinely reach temperatures in the 200 to 500°C range, putting them squarely in the danger zone.
This is not a theoretical risk. One research paper was titled “Vaping THC-O Acetate: Potential for Another EVALI Epidemic,” reflecting the concern among toxicologists that widespread use of THC-O vape products could trigger a new wave of lung injuries.
Legal Status: Classified as Schedule I
For a brief period, THC-O occupied a legal gray area. Some sellers argued it qualified as a hemp derivative under the 2018 Farm Bill, which legalized hemp and its naturally occurring compounds. That argument collapsed in 2023 when the DEA issued a formal ruling: both Delta-8-THC-O-acetate and Delta-9-THC-O-acetate are Schedule I controlled substances.
The DEA’s reasoning was straightforward. Because THC-O does not occur naturally in the cannabis plant, it cannot be classified as hemp. It is a synthetically produced tetrahydrocannabinol with a chemical structure and pharmacological activity similar to the THC found in marijuana. As the agency stated in its letter, THC-O “is properly seen as synthetic THC, not ‘hemp.'” This distinction separates it from Delta-8 THC, which the hemp plant does produce naturally, even if most commercial Delta-8 is also synthesized from CBD.
Under Schedule I classification, THC-O is illegal to manufacture, distribute, or possess at the federal level. Some retailers may still sell it in states with limited enforcement, but purchasing or possessing it carries the same federal legal risk as any other Schedule I substance.
Why THC-O Carries More Unknowns Than Most Cannabinoids
The core problem with THC-O is the gap between how widely it was sold and how little is actually known about it. There are almost no published studies on its effects in humans. The potency estimates come from a single animal study and user self-reports. The safety profile of inhaling acetate-containing cannabinoids is actively concerning based on what researchers already know about ketene gas formation. And the lack of any manufacturing regulation means that even if the compound itself were well understood, the products on the market would still be unpredictable in terms of purity and dose.
For people who encountered THC-O products before the DEA ruling or who still see them for sale, the combination of Schedule I legal status, limited safety data, and documented risks from vaping acetate compounds makes it one of the higher-risk options in the cannabinoid market.